Rockefeller Capital Management
PAVM icon

Rockefeller Capital Management’s PAVmed PAVM Stock Holding History

Rockefeller Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6
Closed -$1K – 3319
2022
Q4 		$1K Hold
6
– – ﹤0.01% 3730
2022
Q3 		$2K Hold
6
– – ﹤0.01% 3615
2022
Q2 		$2K Hold
6
– – ﹤0.01% 3816
2022
Q1 		$3K Buy
+6
New +$4.46K ﹤0.01% 3519
2020
Q4 		– Sell
-22
Closed -$17K – 2973
2020
Q3 		$17K Hold
22
– – ﹤0.01% 1853
2020
Q2 		$21K Hold
22
– – ﹤0.01% 1663
2020
Q1 		$20K Buy
+22
New +$18K ﹤0.01% 1517

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rockefeller Capital Management's PAVM Position: Q1 2023 in Review

Rockefeller Capital Management sold out of PAVmed (PAVM) in Q1 2023, closing a stake of 6 shares — an estimated $1K sold.

Rockefeller Capital Management first reported a position in PAVM in Q1 2020 and held it in 7 quarters. The position peaked at $21K in Q2 2020. 58 funds tracked by Wall St. Rank hold PAVM as of Q1 2023.

  • Rockefeller Capital Management reported no remaining PAVmed position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 6 PAVmed shares in Q1 2023, an estimated $1K.
  • Rockefeller Capital Management first reported a position in PAVmed in Q1 2020 and held it in 7 quarters.
  • Rockefeller Capital Management's PAVmed position peaked at $21K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held PAVmed as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.